Similar articles

• Prevention of fatal pulmonary embolism and mortality in surgical patients: a randomized double-blind comparison of LMWH with unfractionated heparin.

  Haas S, Wolf H, Kakkar AK, Fareed J, Encke A. Haas S, et al. Thromb Haemost. 2005 Oct;94(4):814-9. doi: 10.1160/TH02-10-0189. Thromb Haemost. 2005. PMID: 16270636 Clinical Trial.
• Low molecular weight heparin and prevention of postoperative thrombosis in abdominal surgery.

  Koppenhagen K, Adolf J, Matthes M, Tröster E, Roder JD, Hass S, Fritsche HM, Wolf H. Koppenhagen K, et al. Thromb Haemost. 1992 Jun 1;67(6):627-30. Thromb Haemost. 1992. PMID: 1324534 Clinical Trial.
• Clinical experience of a low molecular weight heparin (Fragmin) in the prevention of thromboembolism after total hip replacement.

  Eriksson BI, Kälebo P, Risberg B. Eriksson BI, et al. Semin Thromb Hemost. 1993;19 Suppl 1:122-7. Semin Thromb Hemost. 1993. PMID: 8395714 Clinical Trial. No abstract available.
• Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?

  Agnelli G. Agnelli G. Haematologica. 1995 Mar-Apr;80(2 Suppl):78-83. Haematologica. 1995. PMID: 7628776 Review. No abstract available.
• A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.

  Kakkar VV, Howes J, Sharma V, Kadziola Z. Kakkar VV, et al. Thromb Haemost. 2000 Apr;83(4):523-9. Thromb Haemost. 2000. PMID: 10780310 Clinical Trial.